FDA Investigates New Salmonella Outbreak Linked to MOGO Moringa Capsules

The U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC), in collaboration with state and local partners, are investigating illnesses in a multistate outbreak of Salmonella Typhimurium infections linked to MOGO-brand moringa powder capsules distributed by MOGO Moringa LLC of St. Louis, Mo.

This is a new outbreak, and the investigation is separate from the multistate outbreak investigation of Salmonella Typhimurium and Salmonella Newport infections linked to recalled dietary supplements containing imported moringa leaf powder that the FDA and CDC reopened yesterday.

Based on epidemiological information collected by CDC, 18 people infected with the outbreak strain of Salmonella have been reported from 14 states. Illnesses started on dates ranging from Feb. 3 to April 7. Of the eight people interviewed, six (75%) reported eating moringa powder capsules, including four who reported MOGO-brand moringa powder capsules. Seven have been hospitalized. No deaths have been reported.

On May 25, MOGO Moringa LLC recalled certain lots of MOGO-brand Pure Moringa Oleifera capsules. Consumers and retailers who purchased recalled MOGO-brand capsules should not eat, sell or further distribute the product and should throw it away, said FDA. Consumers who purchased recalled products can visit the company’s official recall information page.

FDA said it is conducting a traceback investigation to determine a source of contamination and is working with state partners to collect samples.

The agency will update this advisory with new information as it becomes available.